title: Predicting treatment outcome following 24 weeks peginterferon alpha-2a/ribavirin therapy in patients infected with HCV genotype 1: utility of HCV-RNA at day 0, day 22, day 29, and week 6.
authors.forename: Esther
authors.initials: E
authors.lastname: Lukasiewicz
authors.forename: Kristoffer
authors.initials: K
authors.lastname: Hellstrand
authors.forename: Johan
authors.initials: J
authors.lastname: Westin
authors.forename: Carlo
authors.initials: C
authors.lastname: Ferrari
authors.forename: Avidan U
authors.initials: AU
authors.lastname: Neumann
authors.forename: Jean-Michel
authors.initials: JM
authors.lastname: Pawlotsky
authors.forename: Solko W
authors.initials: SW
authors.lastname: Schalm
authors.forename: Stefan
authors.initials: S
authors.lastname: Zeuzem
authors.forename: Bart J
authors.initials: BJ
authors.lastname: Veldt
authors.forename: Bettina E
authors.initials: BE
authors.lastname: Hansen
authors.forename: Elke
authors.initials: E
authors.lastname: Verhey-Hart
authors.forename: Martin
authors.initials: M
authors.lastname: Lagging
mesh_terms: D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D005060:Europe; D005500:Follow-Up Studies; D005838:Genotype; D016174:Hepacivirus / Q000187:drug effects / Q000235:genetics*; D006526:Hepatitis C / Q000097:blood / Q000188:drug therapy* / Q000235:genetics; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000494:pharmacology / Q000627:therapeutic use*; D015337:Multicenter Studies as Topic; D011092:Polyethylene Glycols / Q000494:pharmacology / Q000627:therapeutic use*; D011237:Predictive Value of Tests; D012367:RNA, Viral / Q000097:blood*; D011994:Recombinant Proteins; D012254:Ribavirin / Q000494:pharmacology / Q000627:therapeutic use*; D016896:Treatment Outcome; D019562:Viral Load
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D012367:RNA, Viral; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C100416:peginterferon alfa-2a